GenVec genvec.com


Public list: BIO 2016 (619) Pharma Startups (4732)

GenVec (NASDAQ: GNVC) is a clinical-stage biopharmaceutical company and pioneer in the development of AdenoVerse gene delivery technology platform.

GenVec (NASDAQ: GNVC) is a clinical-stage biopharmaceutical company and pioneer in the development of AdenoVerse gene delivery technology platform.

Company (Acquired)

Phone: 240-632-0740

Fax:

910 Clopper Road
Suite 220N
Gaithersburg, 20878
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
GenVec $103M Jun 16, 2017
Pharmasset $96.3M Jan 19, 2012
Enzo Biochem $0M Nov 21, 2018
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related GenVec Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Adenoviral vector encoding human atonal homolog-1 (hath1) Oct 09, 2015 Apr 24, 2018 Patent
Malaria antigens and methods of use Nov 12, 2013 Dec 05, 2017 Patent
Modified serotype 28 adenoviral vectors May 28, 2013 Oct 17, 2017 Patent
Affenadenovirus (gorilla) or adenoviral vectors and methods of use Jan 11, 2016 Aug 08, 2017 Patent
Herpes simplex virus vaccine May 16, 2013 Jun 13, 2017 Patent
See all 24 patents